Profile data is unavailable for this security.
About the company
LAVA Therapeutics NV, formerly known as Lava Therapeutics BV, is a provider of biotechnology research and development services based in the Netherlands. The Company focuses of developing next generation Vdelta T cell engaging bispecific antibodies to fight cancer.
- Revenue in USD (TTM)6.77m
- Net income in USD-41.97m
- Incorporated2016
- Employees37.00
- LocationLAVA Therapeutics NVYalelaan 60UTRECHT 3584 CMNetherlandsNLD
- Phone+31 30003035
- Websitehttps://www.lavatherapeutics.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Precision BioSciences Inc | 48.73m | -42.53m | 77.95m | 109.00 | -- | 2.49 | -- | 1.60 | -10.96 | -15.86 | 12.68 | 4.53 | 0.2449 | -- | 60.12 | 447,036.70 | -21.37 | -35.35 | -29.50 | -44.22 | -- | -- | -87.28 | -147.50 | -- | -- | 0.543 | -- | 94.15 | 34.96 | 41.67 | -- | -32.01 | -- |
| BioXcel Therapeutics Inc | 1.38m | -179.05m | 78.51m | 74.00 | -- | -- | -- | 56.89 | -6.16 | -6.16 | 0.0474 | -1.89 | 0.0099 | 0.6343 | 8.65 | 18,648.65 | -128.10 | -74.57 | -163.23 | -84.06 | 8.62 | -- | -12,974.86 | -32,300.74 | 2.57 | -21.87 | 2.28 | -- | 268.00 | -- | -8.02 | -- | -43.26 | -- |
| Marinus Pharmaceuticals Inc | 30.99m | -141.41m | 78.55m | 165.00 | -- | 4.66 | -- | 2.53 | -2.63 | -2.63 | 0.5766 | 0.3072 | 0.144 | 1.55 | 6.11 | 187,812.10 | -65.70 | -49.64 | -77.53 | -57.76 | 93.76 | -- | -456.31 | -518.96 | 4.01 | -14.97 | 0.8132 | -- | 21.63 | -- | -613.59 | -- | 7.47 | -- |
| Reviva Pharmaceuticals Holdings, Inc. | 0.00 | -39.26m | 78.73m | 15.00 | -- | 13.77 | -- | -- | -1.66 | -1.66 | 0.00 | 0.2048 | 0.00 | -- | -- | 0.00 | -184.22 | -- | -507.01 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -38.92 | -- | -- | -- |
| Anebulo Pharmaceuticals Inc | 0.00 | -10.49m | 78.84m | 2.00 | -- | 12.15 | -- | -- | -0.4087 | -0.4087 | 0.00 | 0.2502 | 0.00 | -- | -- | 0.00 | -86.04 | -- | -95.37 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -71.89 | -- | -- | -- |
| Provectus Biopharmaceuticals Inc | 557.71k | -3.10m | 79.71m | 4.00 | -- | -- | -- | 142.92 | -0.0074 | -0.0074 | 0.0013 | -0.0181 | 0.32 | -- | 1,282.09 | 139,427.50 | -177.95 | -276.33 | -- | -- | -- | -- | -556.16 | -1,667.76 | -- | -13.22 | -- | -- | -43.61 | -- | 12.74 | -- | -- | -- |
| Connect Biopharma Holdings Ltd (ADR) | 0.00 | -59.50m | 79.90m | 81.00 | -- | 0.8253 | -- | -- | -1.08 | -1.08 | 0.00 | 1.76 | -- | -- | -- | 0.00 | -- | -66.24 | -- | -71.36 | -- | -- | -- | -- | -- | -- | 0.0046 | -- | -- | -- | 49.61 | -- | 10.32 | -- |
| Cognition Therapeutics Inc | 0.00 | -25.79m | 80.08m | 25.00 | -- | 2.63 | -- | -- | -0.8564 | -0.8564 | 0.00 | 0.7609 | 0.00 | -- | -- | 0.00 | -60.26 | -- | -76.27 | -- | -- | -- | -- | -- | -- | -1,878.67 | 0.00 | -- | -- | -- | -20.52 | -- | -- | -- |
| Personalis Inc | 73.48m | -108.30m | 80.14m | 223.00 | -- | 0.6103 | -- | 1.09 | -2.25 | -2.25 | 1.53 | 2.56 | 0.2838 | 5.80 | 4.28 | 329,511.20 | -41.83 | -28.84 | -49.51 | -34.72 | 24.78 | 28.65 | -147.38 | -96.01 | 2.89 | -- | 0.0218 | -- | 12.97 | 14.23 | 4.43 | -- | 6.80 | -- |
| Regencell Bioscience Holdings Ltd | 0.00 | -7.45m | 80.94m | 12.00 | -- | 4.74 | -- | -- | -0.5863 | -0.5863 | 0.00 | 1.31 | 0.00 | -- | -- | 0.00 | -82.73 | -- | -113.11 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 21.15 | -- | -- | -- |
| LAVA Therapeutics NV | 6.77m | -41.97m | 80.97m | 37.00 | -- | 1.58 | -- | 11.96 | -1.58 | -1.58 | 0.2532 | 1.95 | 0.0552 | -- | 2.87 | 182,946.00 | -34.25 | -- | -40.31 | -- | 48.56 | -- | -620.09 | -- | -- | -- | 0.1098 | -- | -65.09 | -- | -31.55 | -- | -- | -- |
| MDxHealth SA - ADR | 75.33m | -39.90m | 81.86m | 300.00 | -- | -- | -- | 1.09 | -1.14 | -1.14 | 0.8428 | -0.0357 | 0.5528 | 11.06 | 6.95 | 251,090.00 | -29.28 | -51.62 | -33.98 | -64.72 | 62.76 | 50.88 | -52.97 | -117.64 | 1.53 | -1.71 | 1.02 | -- | 89.43 | 19.84 | 2.14 | -- | 30.13 | -- |
| Athira Pharma Inc | 0.00 | -117.67m | 82.02m | 65.00 | -- | 0.6275 | -- | -- | -3.09 | -3.09 | 0.00 | 3.41 | 0.00 | -- | -- | 0.00 | -56.25 | -30.73 | -63.93 | -32.46 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -23.04 | -- | -- | -- |
| LifeVantage Corp | 205.45m | 3.60m | 84.33m | 248.00 | 23.75 | 3.15 | 11.59 | 0.4105 | 0.2796 | 0.2796 | 16.01 | 2.11 | 3.20 | 2.53 | 91.56 | 828,443.60 | 5.60 | 11.65 | 8.51 | 18.92 | 79.32 | 82.20 | 1.75 | 3.42 | 1.01 | -- | 0.00 | 5.23 | 3.41 | 0.9838 | -18.59 | -18.77 | -7.98 | -- |
Data as of May 09 2024. Currency figures normalised to LAVA Therapeutics NV's reporting currency: US Dollar USD
15.06%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Redmile Group LLCas of 31 Dec 2023 | 2.07m | 7.89% |
| Tang Capital Management LLCas of 31 Dec 2023 | 840.59k | 3.20% |
| Bruce & Co., Inc.as of 31 Dec 2023 | 771.87k | 2.94% |
| Alpha Wave Global LPas of 31 Dec 2023 | 107.91k | 0.41% |
| PNC Bank, NA (Investment Management)as of 31 Dec 2023 | 65.00k | 0.25% |
| Millennium Management LLCas of 31 Dec 2023 | 28.06k | 0.11% |
| Morgan Stanley & Co. LLCas of 31 Dec 2023 | 24.80k | 0.09% |
| Citadel Securities LLCas of 31 Dec 2023 | 21.55k | 0.08% |
| Pathway Financial Advisors LLCas of 31 Mar 2024 | 14.00k | 0.05% |
| Tower Research Capital LLCas of 31 Dec 2023 | 11.46k | 0.04% |
More ▼
Data from 31 Dec 2023 - 31 Mar 2024Source: FactSet Research Systems Inc.
